Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact
Go back to Pfizer (PFE) to Discontinue Bococizumab Development Program; Sees EPS Impact| PANDORA MEDIA, Inc. (NYSE: P) | Delayed: 72.31 +2.97 (4.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.34 | 52 Week High | $16.23 | |||
| Open | $70.00 | 52 Week Low | $7.10 | |||
| Day High | $72.97 | P/E | N/A | |||
| Day Low | $69.21 | EPS | $-0.15 | |||
| Volume | 3,081,102 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.21 +0.04 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.17 | 52 Week High | $37.39 | |||
| Open | $26.29 | 52 Week Low | $28.25 | |||
| Day High | $26.49 | P/E | 15.88 | |||
| Day Low | $26.11 | EPS | $1.65 | |||
| Volume | 38,768,485 | |||||

